Supplemental material, MSJ831213_supplementary_table_2 for Modelling the impact of multiple sclerosis on life expectancy, quality-adjusted life years and total lifetime costs: Evidence from Australia by Andrew J Palmer, Ingrid van der Mei, Bruce V Taylor, Philip M Clarke, Steve Simpson and Hasnat Ahmad in Multiple Sclerosis Journal</p
Supplemental material, MSJ846100_supplemental_table_2 for Predictors of treatment outcome in patient...
Supplemental material, MSJ846100_supplemental_table_1 for Predictors of treatment outcome in patient...
Supplemental material, MSJ846100_supplemental_table_3 for Predictors of treatment outcome in patient...
Supplemental material, MSJ831213_supplementary_table_1 for Modelling the impact of multiple sclerosi...
Supplemental material, MSJ831213_supplement_2 for Modelling the impact of multiple sclerosis on life...
Supplemental material, MSJ831213_supplement_1 for Modelling the impact of multiple sclerosis on life...
Supplemental material, MSJ831213_supplement_3 for Modelling the impact of multiple sclerosis on life...
Supplemental material, MSJ806103_supplemental_table_2 for Estimation of annual probabilities of chan...
Supplemental material, MSJ806103_supplemental_table_1 for Estimation of annual probabilities of chan...
Objectives: To quantify life expectancy (LE), quality-adjusted life years (QALYs) and total lifetime...
Supplemental material, MSJ796676_supplementary_table_1 for Pediatric-onset multiple sclerosis is ass...
Supplemental material, MSJ848090_supplementary_tables for Decreasing impact of late relapses on disa...
<p>Supplemental material, MSJ775920_supplementary_table_1 for A multicenter randomized controlled tr...
<p>Supplemental material, MSJ775920_supplementary_table_2 for A multicenter randomized controlled tr...
Supplemental material, MSJ848090_supplementary_figure for Decreasing impact of late relapses on disa...
Supplemental material, MSJ846100_supplemental_table_2 for Predictors of treatment outcome in patient...
Supplemental material, MSJ846100_supplemental_table_1 for Predictors of treatment outcome in patient...
Supplemental material, MSJ846100_supplemental_table_3 for Predictors of treatment outcome in patient...
Supplemental material, MSJ831213_supplementary_table_1 for Modelling the impact of multiple sclerosi...
Supplemental material, MSJ831213_supplement_2 for Modelling the impact of multiple sclerosis on life...
Supplemental material, MSJ831213_supplement_1 for Modelling the impact of multiple sclerosis on life...
Supplemental material, MSJ831213_supplement_3 for Modelling the impact of multiple sclerosis on life...
Supplemental material, MSJ806103_supplemental_table_2 for Estimation of annual probabilities of chan...
Supplemental material, MSJ806103_supplemental_table_1 for Estimation of annual probabilities of chan...
Objectives: To quantify life expectancy (LE), quality-adjusted life years (QALYs) and total lifetime...
Supplemental material, MSJ796676_supplementary_table_1 for Pediatric-onset multiple sclerosis is ass...
Supplemental material, MSJ848090_supplementary_tables for Decreasing impact of late relapses on disa...
<p>Supplemental material, MSJ775920_supplementary_table_1 for A multicenter randomized controlled tr...
<p>Supplemental material, MSJ775920_supplementary_table_2 for A multicenter randomized controlled tr...
Supplemental material, MSJ848090_supplementary_figure for Decreasing impact of late relapses on disa...
Supplemental material, MSJ846100_supplemental_table_2 for Predictors of treatment outcome in patient...
Supplemental material, MSJ846100_supplemental_table_1 for Predictors of treatment outcome in patient...
Supplemental material, MSJ846100_supplemental_table_3 for Predictors of treatment outcome in patient...